Viewing Study NCT03455556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-05-03 @ 6:55 AM
Study NCT ID: NCT03455556
Status: TERMINATED
Last Update Posted: 2023-01-06
First Post: 2018-02-28
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mesothelin Positive View
None Stage III Non-Small Cell Lung Cancer AJCC v7 View
None Stage IIIA Non-Small Cell Lung Cancer AJCC v7 View
None Stage IIIB Non-Small Cell Lung Cancer AJCC v7 View
None Stage IV Non-Small Cell Lung Cancer AJCC v7 View
Keywords: